BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19293786)

  • 1. Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results.
    Singh H; Kadiyala H; Bhagwath G; Shethia A; El-Serag H; Walder A; Velez ME; Petersen LA
    Am J Gastroenterol; 2009 Apr; 104(4):942-52. PubMed ID: 19293786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timely follow-up of positive fecal occult blood tests strategies associated with improvement.
    Powell AA; Gravely AA; Ordin DL; Schlosser JE; Partin MR
    Am J Prev Med; 2009 Aug; 37(2):87-93. PubMed ID: 19524390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in the management of positive fecal occult blood tests.
    Rao SK; Schilling TF; Sequist TD
    J Gen Intern Med; 2009 Mar; 24(3):356-60. PubMed ID: 19130147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the follow-up of positive hemoccult screening tests: an electronic intervention.
    Humphrey LL; Shannon J; Partin MR; O'Malley J; Chen Z; Helfand M
    J Gen Intern Med; 2011 Jul; 26(7):691-7. PubMed ID: 21327529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization.
    Miglioretti DL; Rutter CM; Bradford SC; Zauber AG; Kessler LG; Feuer EJ; Grossman DC
    Med Care; 2008 Sep; 46(9 Suppl 1):S91-6. PubMed ID: 18725839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to full colon evaluation for a positive fecal occult blood test.
    Fisher DA; Jeffreys A; Coffman CJ; Fasanella K
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1232-5. PubMed ID: 16775188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?
    Carlson CM; Kirby KA; Casadei MA; Partin MR; Kistler CE; Walter LC
    Arch Intern Med; 2011 Feb; 171(3):249-56. PubMed ID: 20937917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a VHA collaborative to improve follow-up after a positive colorectal cancer screening test.
    Powell AA; Nugent S; Ordin DL; Noorbaloochi S; Partin MR
    Med Care; 2011 Oct; 49(10):897-903. PubMed ID: 21642875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organizational predictors of colonoscopy follow-up for positive fecal occult blood test results: an observational study.
    Partin MR; Burgess DJ; Burgess JF; Gravely A; Haggstrom D; Lillie SE; Nugent S; Powell AA; Shaukat A; Walter LC; Nelson DB
    Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):422-34. PubMed ID: 25471345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated Automated Mobile Text Messaging Reminders for Follow-Up of Positive Fecal Occult Blood Tests: Randomized Controlled Trial.
    Azulay R; Valinsky L; Hershkowitz F; Magnezi R
    JMIR Mhealth Uhealth; 2019 Feb; 7(2):e11114. PubMed ID: 30720439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reasons For Lack of Follow-up Colonoscopy Among Persons With A Positive Fecal Occult Blood Test Result: A Qualitative Study.
    Llovet D; Serenity M; Conn LG; Bravo CA; McCurdy BR; Dubé C; Baxter NN; Paszat L; Rabeneck L; Peters A; Tinmouth J
    Am J Gastroenterol; 2018 Dec; 113(12):1872-1880. PubMed ID: 30361625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the effectiveness of fecal occult blood testing in a primary care clinic by direct colonoscopy referral for positive tests.
    Van Kleek E; Liu S; Conn LM; Hoadley A; Ho SB
    J Healthc Qual; 2010; 32(6):62-9. PubMed ID: 20946427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer screening, comorbidity, and follow-up in elderly patients.
    Garman KS; Jeffreys A; Coffman C; Fisher DA
    Am J Med Sci; 2006 Oct; 332(4):159-63. PubMed ID: 17031239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates and correlates of potentially inappropriate colorectal cancer screening in the Veterans Health Administration.
    Powell AA; Saini SD; Breitenstein MK; Noorbaloochi S; Cutting A; Fisher DA; Bloomfield HE; Halek K; Partin MR
    J Gen Intern Med; 2015 Jun; 30(6):732-41. PubMed ID: 25605531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels and variation in overuse of fecal occult blood testing in the Veterans Health Administration.
    Partin MR; Powell AA; Bangerter A; Halek K; Burgess JF; Fisher DA; Nelson DB
    J Gen Intern Med; 2012 Dec; 27(12):1618-25. PubMed ID: 22810358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the patient activation measure associated with adherence to colonoscopy after a positive fecal occult blood test result?
    Azulay R; Valinsky L; Hershkowitz F; Magnezi R
    Isr J Health Policy Res; 2018 Dec; 7(1):74. PubMed ID: 30577883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer diagnosis improvement project evaluation demonstrates the importance of using multiple measures to track progress toward timeliness goals.
    Partin MR; Powell AA; Nugent S; Ordin DL
    J Healthc Qual; 2013; 35(3):41-8. PubMed ID: 22192595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Direct Access Colonoscopy Clinic: Improving time to colonoscopy for eligible positive faecal occult blood test patients in Broken Hill NSW.
    Whitelaw L; Hammond K; Cumming M; Mansfield K; Saurman E
    Aust J Rural Health; 2020 Feb; 28(1):81-86. PubMed ID: 31650635
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.